跳至主導覽
跳至搜尋
跳過主要內容
澳門理工大學 首頁
English
中文
首頁
研究單位
研究成果
學術履歷
新聞/媒體
按專業知識、姓名或所屬機構搜尋
連絡專家
查看斯高帕斯 (Scopus) 概要
郎 斌
Associate Professor
Associate Professor
,
Peking University Health Science Center - Macao Polytechnic University Nursing Academy
電話
8893 6952 / 8599 3440
電子郵件
blang
mpu.edu
mo
h-index
1147
引文
20
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
研究成果
(51)
新聞/媒體
(2)
類似的個人檔案
(6)
指紋
查看啟用 BIN LANG 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
microRNA 34a
26%
Malignant Neoplasm
25%
Tumor Suppressor Protein
21%
Cancer Growth
18%
Chemotherapy
17%
Renal Cell Carcinoma
17%
Fibulin
17%
Immunoglobulin
17%
Leucine
17%
microRNA 221
17%
Messenger RNA
17%
Neoplasm
12%
Drug Resistance
11%
Carcinogenesis
11%
PUMA Protein
10%
Long Untranslated RNA
8%
Endometrium Carcinoma
8%
Paclitaxel
8%
Bladder Carcinoma
8%
Calcium Ion
8%
Zinc Finger Nuclease
8%
Endonuclease
8%
Secretase
8%
Recurrent Disease
8%
Kruppel Like Factor 4
8%
Rosiglitazone
8%
microRNA 24
8%
Oligodeoxynucleotide
8%
Growth Factor Receptor
8%
microRNA
8%
Cisplatin
8%
Neutralizing Antibody
8%
Epidermal Growth Factor Receptor
8%
Human Papillomavirus
8%
Endometrium Cancer
8%
Carcinoma
8%
Receptor Protein
8%
SARS Coronavirus
8%
Cancer Recurrence
8%
Western Blot
8%
Green Fluorescent Protein
7%
Muscle Invasive Bladder Cancer
6%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
47%
Wart Virus
38%
Epigenetics
20%
Long Non-Coding RNA
17%
Cisplatin
17%
MicroRNA
17%
Promoter Region
17%
Genome Editing
14%
Messenger RNA
13%
Cell Growth
13%
Genomics
13%
Carcinogenesis
12%
Tumor Suppressor Protein
12%
CD44
11%
Human Papillomavirus Type 16
10%
CRISPR
10%
Genotyping
9%
P53 Upregulated Modulator of Apoptosis
8%
Cross Sectional Study
8%
Saos-2 Cells
8%
Neutralizing Antibody
8%
Epidermal Growth Factor Receptor
8%
Enhancer Region
8%
Leucine-Rich Repeat
8%
Immunoglobulin Domain
8%
PTENP1
8%
Deep Sequencing
8%
DNA Methyltransferase
8%
Transcription
8%
Angiogenesis
8%
Notch
8%
Binding Domain
8%
TATA Box
8%
Receptor Binding
8%
GA Binding Protein
8%
Immune Evasion
8%
Sensitive Detection
8%
Osteoblast
8%
Protospacer Adjacent Motif
8%
CRISPR/Cas9
8%
Orthology
8%
Spike
8%
SARS Coronavirus
8%
Real-Time Polymerase Chain Reaction
7%
Guide RNA
7%
Methylation
6%
Immunoreactivity
5%
Biological Functions
5%
Mesenchymal-Epithelial Transition
5%
Medicine and Dentistry
Adrenalectomy
38%
Cancer Cell
21%
Bladder Cancer
18%
Cancer Growth
18%
Pyeloplasty
17%
Primary Hyperaldosteronism
17%
Tumor Suppressor Protein
17%
Open Surgery
17%
Operation Duration
14%
Recurrent Disease
13%
Pheochromocytoma
11%
Bleeding
10%
Neoplasm
10%
Immunoglobulin Domain
8%
Leucine
8%
microRNA 34a
8%
Ureteropelvic Junction Obstruction
8%
Clustered Regularly Interspaced Short Palindromic Repeat
8%
Adenoma
8%
Adrenal Tumor
8%
Cystectomy
8%
Transitional Cell Carcinoma
8%
Laparoendoscopic Single Site Surgery
8%
Hepatocyte Growth Factor
8%
Epidermal Growth Factor Receptor
8%
5637 Cell Line
8%
Cisplatin
8%
Lymph Duct
8%
Chyluria
8%
Pedicle
8%
Cas9
8%
Urothelial Cancer
8%
Kruppel Like Factor 4
8%
Adrenal Cyst
8%
Growth Factor Receptor
8%
Uterine Cancer
8%
Chemotherapy
8%
Clear Cell Renal Cell Carcinoma
8%
Calcium Ion
8%
Aldosterone
7%
Promoter Region
6%
Surgical Anastomosis
6%
Hydrocortisone
6%
TATA Box
5%
Pelvis
5%
Cancer Stem Cell
5%
Conversion to Open Surgery
5%
